Kilitch Drugs (India) Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 454.77 million compared to INR 366.08 million a year ago. Revenue was INR 161.97 million compared to INR 369.86 million a year ago.

Net income was INR 35.64 million compared to INR 28.98 million a year ago. Basic earnings per share from continuing operations was INR 2.29 compared to INR 1.86 a year ago. Diluted earnings per share from continuing operations was INR 2.29 compared to INR 1.86 a year ago.